BRONX, N.Y., Feb. 12, 2017 -- New York City and Bronx area Optometrist Pelham Parkway Vision Center is pleased to announce that they will be making PROKERA® products available to their clients. Treatments with PROKERA® can bring profound relief to optometry clients who are suffering the effects of dry eye and related conditions.
PROKERA® instantly helps to reduce inflammation and accelerate the healing time for dry, inflamed eyes. It is a biologic corneal bandage device that can treat and heal eye conditions such as keratitis (dry eye), persistent epithelial defects, recurrent corneal erosions, neurotrophic corneas, filamentary keratitis, herpetic ulcers, and numerous other diseases of the ocular surface.
Dry eye refers to the inability of the eye to produce tears to help nourish and lubricate the eye. In some cases, sufficient tears are produced, but they are of poor quality, as they do not contain enough healthy oils and mucus. As a result, vision and eye health suffers. Dry eye often affects older adults and can become worse with age. Persons with the condition of dry eye often experience a gritty sensation in the eyes that can burn, feel itchy or cause general irritation. In advanced cases, the eyes can become scratched and damaged, impairing vision, eye health, and quality of life.
When treating dry eye, optometrists aim to help restore and maintain optimal amounts of moisture in the eyes to reduce discomfort and promote health. PROKERA® devices are the only products of their kind that have been cleared by the FDA as a solution for reducing inflammation and promoting the healing and regeneration of the ocular surface.
PROKERA® products promote natural, therapeutic healing with their content of amniotic membrane tissue. The PROKERA® company’s proprietary CryoTek® processing method causes natural therapeutic actions and healthy biological activity so that damaged eye surfaces can heal.
PROKERA® products can bring improved tear production, reduced inflammation and pain, less scarring, clear corneas, improved vision, and better eye health. Quality of life is improved as discomfort fades.
Optometrist Dr. Diana Ilyasova of Pelham Parkway Vision Center appreciates the PROKERA® solution due to its safety, effectiveness, and lack of risk of IOP spikes (intraocular pressure). PROKERA® can also be used in conjunction with other healing solutions such as topical agents.
Dr. Oleg Lisitsyn says, “We are pleased to offer innovative PROKERA® products in our Bronx optometry clinic. We look forward to improving the quality of life of our clients with PROKERA® products.”
Pelham Parkway Vision Center is located at 735 Lydig Avenue in Bronx, New York. Those in New York City area and surrounding communities who would like to learn more about PROKERA® treatments for dry eye or book an appointment may do so by calling (347) 897-5570. Additional information is also available on their website at http://pelhamparkwayvisioncenter.com/.
Pelham Parkway Vision Center, (347) 897-5570


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



